102
Participants
Start Date
February 28, 2002
Primary Completion Date
January 31, 2009
Study Completion Date
June 30, 2012
BMS-247550
One hour infusion on five successive days (daily x 5) every three weeks. Starting dose of 6 mg/m\^2/day for a total per cycle dose of 30 mg/m\^2
Ranitidine
50 mg 30-60 minutes prior to Ixabepilone (BMS-247550)
Diphenhydramine
50 mg intravenously 30-60 minutes prior to Ixabepilone (BMS-247550)
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH